ANIP
ANI PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$76.14
+0.99%Forward multiples
Based on analyst estimates
- P/E forward
- 8.09x
- P/E 2026E
- 8.19x
- P/E 2027E
- 7.26x
- P/E 2028E
- 6.36x
- P/S forward
- 1.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.76x
- PEG TTM
- 0.17x
- Price / book
- 2.93x
- Price / sales
- 1.79x
- Price / cash flow
- 9.23x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 1.74x
- EV / EBITDA
- 6.66x
- EV / EBIT
- 11.34x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026